| Dr Charles Daniel Welch Jr, DMD | |
|
1343 2nd Loop Rd, Florence, SC 29505-2841 | |
| (843) 665-8176 | |
| (843) 665-2601 |
| Full Name | Dr Charles Daniel Welch Jr |
|---|---|
| Gender | Male |
| Speciality | Dentist - Orthodontics And Dentofacial Orthopedics |
| Location | 1343 2nd Loop Rd, Florence, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376625038 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223X0400X | Dentist - Orthodontics And Dentofacial Orthopedics | 1973 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Daniel Welch Jr, DMD 1343 2nd Loop Rd, Florence, SC 29505-2841 Ph: (843) 665-8176 | Dr Charles Daniel Welch Jr, DMD 1343 2nd Loop Rd, Florence, SC 29505-2841 Ph: (843) 665-8176 |
News Archive
A team of UNC scientists has received a five-year $2,308,800 grant from the National Cancer Institute's Cancer Nanotechnology Platform Partnerships to address the critical need for early diagnosis of and more effective treatments for pancreatic cancer.
Researchers at Karolinska Institutet, Sweden, have developed a nanoparticle technology that can be used to stabilise membrane proteins so that their structure can be studied in a lipid environment. The method, described in Nature Methods, makes it possible to access drug targets that previously could not be investigated and therefore potentially allows for the development of novel drugs, therapeutic antibodies and vaccines.
A new study in Obesity investigated the impact of diet quality in mid-to-late-adulthood on visceral and liver fat not solely relying on Body Mass Index.
Researchers at the University of Michigan have identified a new potential therapeutic target for lowering cholesterol that could be an alternative or complementary therapy to statins.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for AR-301, also referred to as Salvecin, the company's fully human anti-Staphylococcal α-toxin IgG1 monoclonal antibody being developed for the treatment of hospital-acquired and ventilator-associated pneumonia (HAP and VAP) caused by Staphylococcus aureus, including multi-drug resistant 'MRSA' strains.
› Verified 6 days ago
Philip Bonds, Dentist Medicare: Not Enrolled in Medicare Practice Location: 1343 2nd Loop Rd, Florence, SC 29505 Phone: 843-665-8176 | |
Dr. Howard Wayne Haney, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 417 W Cheves St, Florence, SC 29501 Phone: 843-665-4344 Fax: 843-665-4619 | |
Paul Gwengi-anam, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 600 E Palmetto St, Florence, SC 29506 Phone: 843-667-9414 Fax: 843-667-1362 | |
Dr. George Paul Economy, D.M.D. P.A. Dentist Medicare: Not Enrolled in Medicare Practice Location: 254 South Irby St., Florence, SC 29501 Phone: 843-667-8880 Fax: 843-667-8887 | |
Dr. Ryan Merlin Meyer, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1507a Heritage Ln, Florence, SC 29505 Phone: 843-665-4477 | |
Dr. Lyle Nelson Mckain Jr., DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1519 Heritage Ln, Florence, SC 29505 Phone: 843-664-8777 | |
Dr. John Breeden Early Jr., DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1840 2nd Loop Rd, Florence, SC 29501 Phone: 843-662-1761 |